The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours.
about
The Role of NG2 Proteoglycan in GliomaTargeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanomaDiversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsetsDynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastomaTheranostic impact of NG2/CSPG4 proteoglycan in cancerExpression sites of colligin 2 in glioma blood vessels.The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling.PDGF-B-driven gliomagenesis can occur in the absence of the proteoglycan NG2Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironmentPDE7B is a novel, prognostically significant mediator of glioblastoma growth whose expression is regulated by endothelial cellsPathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycanEarly contribution of pericytes to angiogenic sprouting and tube formation.Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization.Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma.The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma.Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.Cancer stem cells in the mammalian central nervous system.Experimental iodine-125 seed irradiation of intracerebral brain tumors in nude miceNew molecular targets in angiogenic vessels of glioblastoma tumours.Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survivalExpression of HMP/AN2, a melanoma associated antigen, in murine cerebral gliomas: potential for radioimmunotargeting.A role for the NG2 proteoglycan in glioma progression.The perivascular niche microenvironment in brain tumor progression.The brain tumor microenvironment.Roles of NG2 glial cells in diseases of the central nervous system.The brain tumor microenvironment.Engineering strategies to mimic the glioblastoma microenvironment.Therapeutic potential and challenges of natural killer cells in treatment of solid tumorsBlood-brain barrier pericyte importance in malignant gliomas: what we can learn from stroke and Alzheimer's disease.Glioblastoma invasion and cooption depend on IRE1α endoribonuclease activity.G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency.Progenitor/Stem Cell Markers in Brain Adjacent to Glioblastoma: GD3 Ganglioside and NG2 Proteoglycan Expression.Progenitor cells of the testosterone-producing Leydig cells revealed
P2860
Q26767702-59C6F34D-9192-4036-81C7-C589948DA715Q27326700-864FFDE5-01CD-4149-B07E-CF3EACE83C7AQ27334435-28080D58-CBAB-45F9-AF4C-EB37B4AE42B2Q27344690-02CF7776-443F-4F04-9BFC-5F42CDE3966FQ28085331-E9ECEDFE-5C4F-441A-AC1D-82B4375245DBQ33588445-D5BCBA7E-A663-4248-AACA-78D39843C98BQ33704281-F2AD2172-C045-4379-A71C-E4BD4442D9A0Q33715843-D3658E98-0CC5-4A04-BEFC-DAF845A1C36EQ33743676-961D461F-AA18-45E4-8308-46A9A09831F5Q34156231-95590B50-A71E-4F29-B735-99BB3B1B6AE3Q34312222-14933529-2EEC-4568-BEC7-9EBE8F2A12DCQ34367285-CD0A07AB-2B38-4126-A117-07D57515D30FQ35088365-8B1ECB43-F808-415F-BECC-6451B1D71EFEQ35257150-EC7DC86D-FF54-43B7-9F71-440ABDD1067CQ35828522-5B9085A0-8A50-41BA-9FE1-623A536ADFD2Q36082516-773827AA-0D08-47F3-A712-9D7389BD7546Q36318605-75778AF3-95FD-4B8E-8E0C-43F24980F4C1Q36326878-829A9ABF-75C1-4342-AA51-674D72D7DFD7Q37106536-584FFA94-92DD-463E-9907-C9CE3FECD8FDQ37299271-91CA9C2E-C7A2-4127-AF9A-8D6ECC6A01A0Q37340951-544DD4E0-5A5E-4414-8E68-14E53DF4DE58Q37406681-61369A5C-7B85-4163-9385-1015DA98E962Q37780433-705626FA-3CE3-4B5A-820C-ECED50539985Q37858940-7479022C-91F7-4658-A339-69DE100A29F9Q37959796-02898C9C-8122-45F0-9F5B-258CDB3BAB17Q37989468-90C748C5-EC20-465C-8525-F6835D0FED67Q38244936-C0D5E1CD-03E5-4CB2-99E3-99CE8EF632E9Q38478878-B2B92E8A-18B9-4619-A79E-3C22BB1888CFQ38765529-B3FD1190-B2CE-489B-A3CE-3FA6BF4FCF57Q38839149-B220E4F0-D191-42D3-B4D8-70A56E7E1E93Q39331096-569DC75D-D82D-4723-B695-746B703D183AQ40080387-8FB8B0DD-7998-4449-9376-F86CF7319BF6Q42151708-7B9DF691-5019-4F4D-9E74-02691A59C57E
P2860
The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
The glial precursor proteoglyc ...... human malignant brain tumours.
@en
type
label
The glial precursor proteoglyc ...... human malignant brain tumours.
@en
prefLabel
The glial precursor proteoglyc ...... human malignant brain tumours.
@en
P2093
P2860
P1476
The glial precursor proteoglyc ...... human malignant brain tumours
@en
P2093
B B Tysnes
G J Pilkington
J M Levine
R Bjerkvig
R Mahesparan
S Al-Sarraj
T Furmanek
P2860
P304
P356
10.1046/J.1365-2990.2002.00412.X
P577
2002-10-01T00:00:00Z